News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- STAT Plus: U.S. antitrust regulators are investigating a key supplier of radiology medicines
- Obesity surgery may lower risk of heart attack and stroke in diabetics
- Apple and Zimmer Biomet launch 10,000-patient Apple Watch study in hip and knee surgeries
- EU expands look at Zhejiang Huahai as impurities show up in other ‘sartans’
- J&J sees ‘evolution in pricing, not a revolution’ in 2019
- Sanofi, Regeneron score positive Dupixent data in sinusitis as they await key FDA asthma verdict
- China slaps monstrous $1.3B penalty on vaccine scandal culprit Changsheng
- As U.K. politicians fret Brexit will ‘decimate medical research,’ AstraZeneca sticks to R&D plan
- STAT Plus: Pharmalittle: Legal issues loom over disclosing prices in TV ads; AstraZeneca halts U.K. investment over Brexit worries
- News of Note—Zhejiang Huahai Pharmaceutical gets some cash; Merck wins an award
- Nearing phase 3, resTORbio posts new data on infection drug
- Seeking global deals, Taiho swells its U.S.-based VC fund to $300M
- In worrying trend, vaccination rates in U.S. children keep dropping: CDC reports
- STAT Plus: There’s a legal battle looming over Trump’s new proposal on drug ads. Here’s what’s at the heart of it
- UCSF settles sexual harassment suit involving star researcher for $150,000